Literature DB >> 17554568

Flucloxacillin treatment of Staphylococcus aureus meningitis.

S R Ritchie1, P Rupali, S A Roberts, M G Thomas.   

Abstract

In this paper, we aimed to evaluate the efficacy of flucloxacillin treatment of meningitis caused by methicillin-sensitive Staphylococcus aureus. We identified 33 patients with meningitis due to S. aureus; eight had community-acquired meningitis and 25 had neurosurgical meningitis. Six of the eight patients with community-acquired meningitis were cured. Eighteen of the 22 patients treated with flucloxacillin were cured without relapse (86%, 95%CI 65-97%) and their cerebrospinal fluid (CSF) cultures were sterile after a median of 3 days of treatment. The cure rate for 12 patients who also received an additional antibiotic at the outset of treatment was 75% (95%CI 43-95%). This was not different to the cure rate for the ten patients who received flucloxacillin alone 90% (95%CI 56-100%). We conclude that flucloxacillin is an effective treatment for meningitis caused by S. aureus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17554568     DOI: 10.1007/s10096-007-0324-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   5.103


  12 in total

Review 1.  The management of neurosurgical patients with postoperative bacterial or aseptic meningitis or external ventricular drain-associated ventriculitis. Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy.

Authors: 
Journal:  Br J Neurosurg       Date:  2000-02       Impact factor: 1.596

2.  Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections.

Authors:  J G Kane; R H Parker; G W Jordan; P D Hoeprich
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

3.  Flucloxacillin: a new semisynthetic isoxazolyl penicillin.

Authors:  G P Bodey; C Vallejos; D Stewart
Journal:  Clin Pharmacol Ther       Date:  1972 Jul-Aug       Impact factor: 6.875

4.  Staphylococcus aureus meningitis: 26 years' experience at Vancouver General Hospital.

Authors:  F J Roberts; J A Smith; K R Wagner
Journal:  Can Med Assoc J       Date:  1983-06-15       Impact factor: 8.262

5.  Staphylococcus aureus meningitis.

Authors:  I W Fong; P Ranalli
Journal:  Q J Med       Date:  1984

6.  Brain abscess. A study of 45 consecutive cases.

Authors:  C H Chun; J D Johnson; M Hofstetter; M J Raff
Journal:  Medicine (Baltimore)       Date:  1986-11       Impact factor: 1.889

7.  Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies.

Authors:  R Nau; H W Prange; M Kinzig; A Frank; A Dressel; P Scholz; H Kolenda; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

8.  Disposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy.

Authors:  R Nau; C Lassek; M Kinzig-Schippers; A Thiel; H W Prange; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

9.  Extravascular penetration of highly protein-bound flucloxacillin.

Authors:  T Bergan; A Engeset; W Olszewski; N Ostby; R Solberg
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

10.  Co-trimoxazole versus nafcillin in the therapy of experimental meningitis due to Staphylococcus aureus.

Authors:  W M Scheld; J M Keeley; M R Field; J P Brodeur
Journal:  J Antimicrob Chemother       Date:  1987-05       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.